A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement - Eriksson, B I; Borris, L C; Dahl, O E (Circulation, 2006)
, et al; ODIXa-HIP Study Investigators.